My Size Q2 Loss Widens 289% as Cash Drops to $453K; Going Concern and Nasdaq MVLS Deficiency Flagged
MYSZ sits 17% above its 52-week low of $2.643 on elevated volume (6.6× avg).
Summary
My Size's Q2 loss widened to $1.75M while cash dropped to $453K, triggering a going concern warning and revealing a Nasdaq MVLS deficiency of $2.3M against a $5.0M threshold.
Key Events · Earnings and Guidance · MYSZ
-
Q2 Loss Widens 289%
Net loss for Q2 2026 was $1.75M, up from $450K in Q2 2025, driven by higher operating expenses across all segments.
-
Cash Drops to $453K
Cash and cash equivalents fell to $453K as of June 30, 2026, from $2.3M at December 31, 2025, with management stating existing cash funds operations for less than 12 months.
-
Going Concern Warning Reiterated
Management expresses substantial doubt about the company's ability to continue as a going concern, citing constrained liquidity and imminent risk of default on debt obligations.
-
Nasdaq MVLS Deficiency
As of August 13, 2026, MVLS was approximately $2.3M, below the $5.0M threshold under Nasdaq's new rule (currently stayed pending SEC review), adding a second delisting risk.
Analysis · MYSZ · Technology
My Size's Q2 2026 results show a sharply deteriorating financial position. Revenue grew 53% to $3.07M, but net loss ballooned 289% to $1.75M, and cash and equivalents fell to just $453K from $2.3M at year-end. Management reiterates substantial doubt about its ability to continue as a going concern, stating existing cash funds operations for less than 12 months. The company also discloses its Market Value of Listed Securities is approximately $2.3M, below the $5.0M threshold under Nasdaq's new MVLS rule (currently stayed pending SEC review), creating a second delisting risk alongside the minimum bid price issue. The 1-for-8 reverse split executed August 12 was designed to address the bid price deficiency, but the MVLS shortfall remains unresolved. A litigation settlement of NIS 425K (~$143K) adds to near-term cash obligations. This filing quantifies the severity of the liquidity crisis and the dual Nasdaq compliance threats.
At the time of this filing, MYSZ was trading at $3.08 on NASDAQ in the Technology sector, with a market capitalization of approximately $18M. The 52-week trading range was $2.64 to $11.84. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.